News Sentiment

NBP sentiment intelligence

NovaBridge Biosciences news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.78 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-6.3% over one week, +18.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

NovaBridge Biosciences (NBP) Holds Near Support Amid Modest Pullback - Combination Correction

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -6.3% Price reacting lower
Trend fit Trend inactive 18.7% over four weeks
Fair value -14.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 35
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 6
simplywall.st 6
TradingView 5
GlobeNewswire 4
TradingKey 3
dars.gov.et 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 11
Deals and strategy 2
Analyst action 1
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52
Investing.com Canada Direct company coverage

NovaBridge Biosciences CMO Dennis Andrew sells $5,606 in shares By Investing.com

NovaBridge Biosciences' Chief Medical Officer, Dennis Phillip Andrew, sold $5,606 worth of company shares on June 18, 2026, disposing of 8,494 ordinary shares at $0.66 per share. This transaction occurred after acquiring 23,695 ordinary shares on June 17, 2026, and also involved

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:40
Source
Investing.com Canada
TradingKey Direct company coverage

Novabridge Biosciences ADR (NBP) Institutional Confidence

This article from TradingKey provides an overview of the institutional confidence in Novabridge Biosciences ADR (NBP). It lists major institutional shareholders and their recent activity, showing that several firms have significantly increased their holdings in NBP. The company's

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 10:39
Source
TradingKey
TradingKey Direct company coverage

Novabridge Biosciences ADR (NBP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Novabridge Biosciences ADR (NBP). It indicates that the company has distributed $0.00 in dividends over the past five years and reports no data for stock splits. The current stock price for NBP is $1.485, r

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 09:09
Source
TradingKey
TradingKey Direct company coverage

Novabridge Biosciences ADR (NBP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Novabridge Biosciences ADR (NBP), focusing on key metrics like P/E, P/B, P/S, and P/CF. However, it states that relevant data for these valuation ratios have not yet been disclosed by the company. The article also provides current st

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 05:40
Source
TradingKey